Earlier this year, Philips acquired NightBalance, a Netherlands-based company that designed a device to treat positional obstructive sleep apnea. Now that device, NightBalance Lunoa, has received 510(k) clearance from the US FDA.
The NightBalance Lunoa works by providing patients with gentle vibrations to change sleeping positions, helping to prevent apneas from occurring during sleep. By continuously monitoring patients’ sleep patterns, the NightBalance Lunoa device can adjust the intensity of its vibrations to meet the needs of each patient.
The patient portal interface is user-friendly and accessible, so patients can keep track of their sleep position, movement, and treatment duration and share their data with care providers.
Equipped with a travel case, the device and its accessories can be stored and transported.
The NightBalance Lunoa is currently available only to sleep-center-capable DMEs in California, Washington, Oregon, and Texas. The company expects to expand that availability periodically and to launch commercially in 2019.